Maze Therapeutics
A Senior Medical Director at Maze Therapeutics leads clinical development programs for early-stage genetic therapies targeting kidney and metabolic diseases. The role involves designing and analyzing clinical trials, managing regulatory document preparation, and collaborating with cross-functional teams including operations and external investigators. This senior leadership position plays a pivotal role in translating genetic insights into innovative treatments for patients.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2018
Maze Therapeutics (branded "Genetic Navigators") is a biotechnology company that translates human genetic data into validated drug targets. They combine large-scale human genetics, computational analysis, and functional genomics to prioritize targets with strong causal evidence. Their platform is designed to accelerate and de-risk drug discovery, supporting internal development programs and collaborations with partners to advance new therapies.
Foresite Capital Management IV LLC Sells 1,589,262 Shares of Maze Therapeutics, Inc. $MAZE
11 hours ago
Foresite Capital Management V LLC Sells 258,900 Shares of Maze Therapeutics, Inc. $MAZE
11 hours ago
Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Maze Therapeutics.
45% above the average for this role
Maze Therapeutics Executive Sells All Common Stock Holdings
4 days ago
Executive Medical Director
Denali Therapeutics
Director, Clinical Scientist
Spyre Therapeutics
Executive Medical Director
Cogent Biosciences
Senior Director, Clinical Research - Neurodegeneration
Alnylam Pharmaceuticals
Study Responsible Physician, Senior Director, Clinical Research
Eikon Therapeutics
Vice President, Clinical Operations
Alkeus Pharmaceuticals